Significant Insider buy of Infinity Pharmaceuticals (INFI) Shares Breaks neutral Trend of Last Quarter

Thursday, October 05, 2017 10:15 PM ET

Significant Insider buy of Infinity Pharmaceuticals (INFI) Shares Breaks neutral Trend of Last Quarter

An insider — BVF Partners Il Lp, 10% Owner — purchased 1,600,046 shares of Infinity Pharmaceuticals having a market value of approximately $2,008,076 today, as revealed in a form 4 document filed with the SEC. This is the first insider buy/sell trade in the past 90 days.

The number of buy-sell trades for Infinity Pharmaceuticals is close to that of the 183 member peer company average. The Biotechnology & Medical Research peer group saw 227 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares per buy/sell trade transacted by Infinity Pharmaceuticals insiders is higher. Within the peer group there were 8,599,879 shares purchased and 51,170,539 shares sold with company insiders disposing of 187,536 shares on average.

The data obtained in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.